Hagens Berman Sobol Shapiro LLP recognizes contribution of key partners

Hagens Berman LLP, a Seattle-based law firm representing plaintiffs in class-action and multi-party large-scale litigation, today unveiled its new firm name - Hagens Berman Sobol Shapiro LLP. The new name includes the names of two of the firm's senior partners, Thomas Sobol and Anthony Shapiro.

The firm's managing partner, Steve Berman, says the name change is due recognition of Sobol and Shapiro's notable contributions to Hagens Berman over the past several years, as well as their prominent roles in high-profile litigation.

"Tom Sobol and Tony Shapiro have brought tenacity, talent and expertise that have been integral to the growth and success of our firm," said Berman. "In particular their contributions have had a very significant impact in the growth of our firm as a national presence."

Hagens Berman Sobol Shapiro was founded in 1993 in Seattle, and now has offices in Los Angeles, Chicago, Phoenix and Cambridge.

Thomas Sobol is located at Hagens Berman Sobol Shapiro's Cambridge office where he currently leads drug pricing litigation efforts against several pharmaceutical companies. Recently, Mr. Sobol spearheaded the litigation against GlaxoSmithKline and TAP Pharmaceuticals, which brought the companies' fraudulent schemes to light and resulted in respective $75 million and $150 million settlements for consumers.

Sobol's accomplishments also include his role in the groundbreaking tobacco litigations, in which he represented Massachusetts, New Hampshire and Rhode Island. His work led to significant injunctive relief and monetary recovery of more than $10 billion to those states.

Tony Shapiro is a partner in the firm's Seattle office, where his practice focuses on the prosecution of antitrust and catastrophic personal injury cases. Shapiro has handled hundreds of personal injury cases including numerous wrongful death lawsuits, many resulting in multi-million dollar verdicts and settlements. In the antitrust field, Shapiro has played a prominent role in Brand Name Prescription Drug litigation, the Linerboard antitrust litigation, the DRAM antitrust litigation and the firm's groundbreaking Visa/MasterCard case. His prosecution of claims against the Alyeska Pipeline Service Company after the 1989 Exxon Valdez oil spill ultimately resulted in a $98 million settlement for plaintiffs.

"Tom and Tony's track record embodies the excellence and innovation that defines Hagens Berman's approach to litigation," said Steve Berman. "As we champion the cause of investors, consumers, workers, and the environment, we look forward to the knowledge and leadership they will continue to bring to the team."

In addition, the firm is changing its website URL to www.hbsslaw.com.